Clinical Trials Browser

Unresectable Metastatic Colorectal Cancer × pembrolizumab × Clear all

NCT04991948 2022-03-09

Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

Phase 1 Recruiting

Gastrointestinal

Unresectable Metastatic Colorectal Cancer